{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:47:26Z","timestamp":1761709646074,"version":"3.44.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.transproceed.2019.04.055","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T08:17:13Z","timestamp":1562746633000},"page":"1717-1726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["High Cardiovascular Risk Profile in Young Patients on the Kidney Transplant Waiting List"],"prefix":"10.1016","volume":"51","author":[{"given":"Nils","family":"M\u00fclling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Kallenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Benson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Dolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kribben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2019.04.055_bib1","first-page":"e004251","article-title":"Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study","volume":"4","author":"Neovius","year":"2014","journal-title":"BMJ Ppen"},{"key":"10.1016\/j.transproceed.2019.04.055_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10741-014-9460-9","article-title":"Chronic kidney disease and cardiovascular complications","volume":"20","author":"Di Lullo","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.transproceed.2019.04.055_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrcardio.2013.15","article-title":"Management of cardiovascular disease in patients with kidney disease","volume":"10","author":"Kahn","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib4","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1523-1755.2003.00838.x","article-title":"Level of kidney function as a risk factor for cardiovascular outcomes in the elderly","volume":"63","author":"Manjunath","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2019.04.055_bib5","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1681\/ASN.2004121092","article-title":"Impact of cadaveric renal transplantation on survival in patients listed for transplantation","volume":"16","author":"Oniscu","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5 Suppl. 3","key":"10.1016\/j.transproceed.2019.04.055_bib7","first-page":"S11","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease","volume":"47","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2019.04.055_bib8","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1681\/ASN.2004070597","article-title":"Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease","volume":"16","author":"Weiner","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib9","first-page":"249","article-title":"Effect of anemia correction on left ventricular hypertrophy in patients with modestly high hemoglobin level and chronic kidney disease","volume":"62","author":"Akaishi","year":"2013","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.055_bib11","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.055_bib12","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.055_bib13","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/ndt\/gfh941","article-title":"Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction","volume":"20","author":"Kalantar-Zadeh","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2019.04.055_bib14","first-page":"70","article-title":"Hypoalbuminemia seems to be associated with a higher rate of hospitalization in hemodialysis patients","volume":"38","author":"Antunes","year":"2016","journal-title":"J\u00a0Bras Nefrol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1523-1755.2000.00172.x","article-title":"The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group","volume":"58","author":"Kaysen","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2019.04.055_bib16","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2019.04.055_bib17","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1523-1755.2002.kid562.x","article-title":"C-reactive protein and cardiovascular disease in peritoneal dialysis patients","volume":"62","author":"Ducloux","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2019.04.055_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/08860220701810539","article-title":"Serum CRP levels in pre-dialysis patients","volume":"30","author":"Razeghi","year":"2008","journal-title":"Ren Fail"},{"key":"10.1016\/j.transproceed.2019.04.055_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000368940","article-title":"Update on inflammation in chronic kidney disease","volume":"39","author":"Akchurin","year":"2015","journal-title":"Blood Purif"},{"key":"10.1016\/j.transproceed.2019.04.055_bib20","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","article-title":"Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure","volume":"55","author":"Stenvinkel","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2019.04.055_bib21","doi-asserted-by":"crossref","first-page":"20a","DOI":"10.1016\/j.amjcard.2005.11.012","article-title":"Inflammation in renal disease","volume":"97","author":"Vidt","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib22","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.12.030","article-title":"Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD","volume":"55","author":"Babitt","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2019.04.055_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.1998.18.555","article-title":"Proinflammatory cytokines lowering erythropoietin production","volume":"18","author":"Jelkmann","year":"1998","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.transproceed.2019.04.055_bib24","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2215\/CJN.00380111","article-title":"Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease","volume":"6","author":"Wagner","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/sdi.12107","article-title":"How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: Can reduction of inflammation improve ESA dose response?","volume":"26","author":"Kovesdy","year":"2013","journal-title":"Semin Dial"},{"key":"10.1016\/j.transproceed.2019.04.055_bib26","first-page":"653","article-title":"Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling","volume":"27","author":"Liu","year":"2014","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib27","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transproceed.2019.04.055_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/j.ajkd.2010.01.019","article-title":"Association of uric acid with change in kidney function in healthy normotensive individuals","volume":"56","author":"Bellomo","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2019.04.055_bib29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ndt\/gfu352","article-title":"Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study","volume":"30","author":"Jing","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2019.04.055_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.HYP.0000085858.66548.59","article-title":"Hyperuricemia in childhood primary hypertension","volume":"42","author":"Feig","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.transproceed.2019.04.055_bib31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2019.04.055_bib32","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.HYP.0000248752.08807.4c","article-title":"Uric acid and the development of hypertension: the normative aging study","volume":"48","author":"Perlstein","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.transproceed.2019.04.055_bib33","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971\u20131992. National Health and Nutrition Examination Survey","volume":"283","author":"Fang","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2019.04.055_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2008.05.022","article-title":"Uric acid: a marker of increased cardiovascular risk","volume":"202","author":"Gagliardi","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.transproceed.2019.04.055_bib35","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/ndt\/gfm783","article-title":"Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia","volume":"23","author":"Sanchez-Lozada","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2019.04.055_bib36","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1681\/ASN.2008010080","article-title":"Elevated uric acid increases the risk for kidney disease","volume":"19","author":"Obermayr","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib37","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/ndt\/gft029","article-title":"Uric acid and chronic kidney disease: which is chasing which?","volume":"28","author":"Johnson","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2019.04.055_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.phrs.2014.06.011","article-title":"Statins in chronic kidney disease and kidney transplantation","volume":"88","author":"Kassimatis","year":"2014","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.transproceed.2019.04.055_bib39","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.055_bib40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2019.04.055_bib41","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1681\/ASN.2014010062","article-title":"HDL in CKD: how good is the \u201cgood cholesterol?\u201d","volume":"25","author":"de Boer","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib42","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1093\/eurheartj\/eht382","article-title":"Jekyll and Hyde of HDL: a lipoprotein with a split personality","volume":"34","author":"Shah","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.transproceed.2019.04.055_bib43","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/ndt\/gft080","article-title":"Uraemic dyslipidaemia revisited: role of high-density lipoprotein","volume":"28","author":"Speer","year":"2013","journal-title":"Nephrol dial transplant"},{"key":"10.1016\/j.transproceed.2019.04.055_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.055_bib45","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.055_bib46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2019.04.055_bib47","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.transproceed.2013.03.033","article-title":"Impact of patient characteristics and comorbidity profile on activation of patients on the kidney transplantation waiting list","volume":"45","author":"Akolekar","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2019.04.055_bib48","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ki.2014.384","article-title":"Obesity, metabolic health, and the risk of end-stage renal disease","volume":"87","author":"Panwar","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2019.04.055_bib49","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2215\/CJN.08310813","article-title":"Differential association of body mass index with access to kidney transplantation in men and women","volume":"9","author":"Gill","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib50","doi-asserted-by":"crossref","first-page":"e952","DOI":"10.1097\/MD.0000000000000952","article-title":"Prevalence and Incidence of hypertension in the general adult population: results of the CARLA-Cohort Study","volume":"94","author":"Lacruz","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.transproceed.2019.04.055_bib51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/jhh.2014.82","article-title":"Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008\u201311","volume":"29","author":"Neuhauser","year":"2015","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.transproceed.2019.04.055_bib52","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.ajkd.2006.08.019","article-title":"J-shaped mortality relationship for uric acid in CKD","volume":"48","author":"Suliman","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2019.04.055_bib53","article-title":"S2e-Leitlinie Gichtarthritis (fach.rztlich)","author":"Langfassung","year":"2016","journal-title":"[S2e-Guideline Gouty Arthritis, German Society for Rheumatology]"},{"key":"10.1016\/j.transproceed.2019.04.055_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","article-title":"Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel","volume":"58","author":"Halevy","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib55","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2019.04.055_bib56","first-page":"127","article-title":"Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition","volume":"19","author":"de Mutsert","year":"2009","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.transproceed.2019.04.055_bib57","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2369-14-242","article-title":"Hypoalbuminemia in hemodialyzed end stage renal disease patients: risk factors and relationships--a 2 year single center study","volume":"14","author":"Sridhar","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib58","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1093\/ndt\/gfs075","article-title":"Hypoalbuminaemia, systemic albumin leak and endothelial dysfunction in peritoneal dialysis patients","volume":"27","author":"Yu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2019.04.055_bib59","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.2215\/CJN.00710111","article-title":"C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients","volume":"6","author":"Bazeley","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib60","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib61","first-page":"176","article-title":"Predictive value of malnutrition markers for mortality in peritoneal dialysis patients","volume":"21","author":"Leinig","year":"2011","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.transproceed.2019.04.055_bib62","doi-asserted-by":"crossref","first-page":"e84943","DOI":"10.1371\/journal.pone.0084943","article-title":"Prevalence of anemia in chronic kidney disease in the United States","volume":"9","author":"Stauffer","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.transproceed.2019.04.055_bib63","first-page":"76","article-title":"Anemia in patients undergoing ambulatory peritoneal dialysis: prevalence and associated factors","volume":"38","author":"Oliveira","year":"2016","journal-title":"J\u00a0Bras Nefrol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib64","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00103-013-1670-0","article-title":"Prevalence of dyslipidemia among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS 1)","volume":"56","author":"Scheidt-Nave","year":"2013","journal-title":"Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz"},{"key":"10.1016\/j.transproceed.2019.04.055_bib65","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2019.04.055_bib66","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2213-8587(16)30156-5","article-title":"Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials","volume":"4","author":"Herrington","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12882-017-0545-2","article-title":"Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection","volume":"18","author":"Reith","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.transproceed.2019.04.055_bib68","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.2013050482","article-title":"HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction","volume":"25","author":"Zewinger","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"year":"2013","series-title":"2013. KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease","key":"10.1016\/j.transproceed.2019.04.055_bib69"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519304695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519304695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:30:20Z","timestamp":1758576620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134519304695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0041134519304695"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.04.055","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Cardiovascular Risk Profile in Young Patients on the Kidney Transplant Waiting List","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.04.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}